We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACEL icon
2151
Accel Entertainment
ACEL
$1.01B
$234K ﹤0.01%
30,368
WCC
2152
WESCO International
WCC
$17.5B
$233K ﹤0.01%
1,858
-35
-2% -$4.41K
BKI
2153
DELISTED
Black Knight, Inc. Common Stock
BKI
$232K ﹤0.01%
3,765
-9
-0.2% -$547
MCFT icon
2154
MasterCraft Boat Holdings
MCFT
$598M
$232K ﹤0.01%
8,982
BLFY
2155
DELISTED
Blue Foundry Bancorp
BLFY
$232K ﹤0.01%
18,027
CIR
2156
DELISTED
CIRCOR International, Inc
CIR
$231K ﹤0.01%
9,640
CCBG icon
2157
Capital City Bank Group
CCBG
$898M
$230K ﹤0.01%
7,091
-822
-10% -$28K
AXGN icon
2158
Axogen
AXGN
$2.58B
$230K ﹤0.01%
23,064
OFIX icon
2159
Orthofix Medical
OFIX
$415M
$230K ﹤0.01%
11,204
+570
+5% +$10.1K
HDSN
2160
Hudson Technologies
HDSN
$239M
$230K ﹤0.01%
22,716
PTLO icon
2161
Portillo's
PTLO
$365M
$230K ﹤0.01%
14,070
STRO icon
2162
Sutro Biopharma
STRO
$353M
$229K ﹤0.01%
2,838
+430
+18% +$29.9K
OPK icon
2163
Opko Health
OPK
$1.04B
$229K ﹤0.01%
183,333
-31,048
-14% -$48.9K
DYN icon
2164
Dyne Therapeutics
DYN
$4.85B
$229K ﹤0.01%
19,766
BLNK icon
2165
Blink Charging
BLNK
$87.1M
$229K ﹤0.01%
20,880
NVRI icon
2166
Enviri
NVRI
$564M
$229K ﹤0.01%
36,367
-5,916
-14% -$35.3K
OSPN icon
2167
OneSpan
OSPN
$624M
$229K ﹤0.01%
20,440
CENX icon
2168
Century Aluminum
CENX
$4.59B
$228K ﹤0.01%
27,830
FLIC
2169
DELISTED
First of Long Island Corp
FLIC
$228K ﹤0.01%
12,646
ANIK icon
2170
Anika Therapeutics
ANIK
$283M
$227K ﹤0.01%
7,685
-845
-10% -$24K
EQRX
2171
DELISTED
EQRx, Inc. Common Stock
EQRX
$227K ﹤0.01%
92,456
-18,932
-17% -$74.6K
AVIR icon
2172
Atea Pharmaceuticals
AVIR
$406M
$227K ﹤0.01%
47,234
TTI icon
2173
TETRA Technologies
TTI
$1.25B
$227K ﹤0.01%
65,618
EB
2174
DELISTED
Eventbrite
EB
$227K ﹤0.01%
38,737
DOX icon
2175
Amdocs
DOX
$6.23B
$227K ﹤0.01%
2,496
+12
+0.5% +$1.02K

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.